Updated:
Guy's & St Thomas' Foundation
Founded in 2014 as an independent charity, Guy's & St Thomas' Foundation traces its assets to historic endowments tied to the Guy's and St Thomas'...
Guy's & St Thomas' Foundation
Founded in 2014 as an independent charity, Guy's & St Thomas' Foundation traces its assets to historic endowments tied to the Guy's and St Thomas' hospitals. Under CEO Laurie Lee and CIO Emma Davies, the foundation operates outside the NHS balance sheet, managing its own endowment to fund both health-impact grants and hospital-related capital projects. It maintains close operating ties with Guy's and St Thomas' NHS Foundation Trust and research partner King's College London. The endowment pursues a hybrid approach, mixing institutional fund commitments with direct investments and substantial real-asset holdings in London's SE1 corridor. The listed portfolio spans venture capital, buyout, growth, private credit, secondaries, and special situations. Direct property assets form a distinctive anchor: holdings include Becket House in Westminster, the mixed-use Orchard Lisle and Iris Brook Houses near London Bridge, and the Royal Street development site in Lambeth. The foundation co-develops the Snowsfields Quarter life sciences hub alongside Oxford Properties, while also partnering with Stanhope PLC on Royal Street. The agricultural holdings portfolio extends the real-asset footprint across the United Kingdom. In recent years, the foundation has committed to restructuring its investment office to support the dual mandate of return generation and measurable health impact. A broader team of investment professionals manages the pooled endowment, with the foundation positioning itself as a founding partner of SC1, the South London life sciences innovation district. The foundation is a member of the UN Global Compact, Climate Action 100+, and UKSIF, and it co-founded the Long Term Investors for People's Health (LIPH) global alliance. The foundation's architecture differs from standard NHS-linked charities because it operates an independent, fully discretionary endowment with a dedicated CIO — a structure that resembles a major US medical foundation more than a typical UK hospital charity. Its ability to act as a developer, direct investor, and grantmaker from a single balance sheet gives it a multi-tool posture rarely seen among UK health foundations.
General information
Firm type
Endowment / Foundation
Year founded
2014
AUM
Undisclosed (£1bn+ endowment, approximately $1.3B) (Altss estimate)
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Principals
Emma Davies
Chief Investment Officer
Laurie Lee
Chief Executive Officer
Sector focus
Frequently asked questions
How is Guy's & St Thomas' Foundation related to the NHS trust?
The foundation is an independent charity, separate from the NHS budget, but it operates as the official charity for Guy's and St Thomas' NHS Foundation Trust. It manages its own endowment and directs capital toward both trust-related capital projects and wider urban health initiatives. The two entities share a closely linked history and ongoing partnership without financial consolidation.
What is the foundation's investment model?
The foundation deploys a pooled endowment across a diversified portfolio that includes direct real estate, venture capital, private equity, private credit, and special situations. It combines fund commitments with direct co-investments and operates an in-house property portfolio concentrated in central London's SE1 district. The CIO oversees this hybrid model with a small internal investment team.
How large is the foundation's real estate portfolio?
The property portfolio is substantial, comprising commercial, residential, and mixed-use assets adjacent to its hospital partners. Confirmed holdings include Becket House, Orchard Lisle and Iris Brook Houses, Royal Street, and the Snowsfields Quarter life sciences development. Agricultural land holdings extend the real-asset footprint across the United Kingdom.
Does the foundation invest for financial return or health impact?
It pursues both objectives under a dual-mandate structure. The endowment's financial returns fund grant-making and hospital capital projects, while the foundation also measures and targets direct health impact through its investments. It co-founded the Long Term Investors for People's Health alliance to formalize health-outcome integration into institutional portfolios.
Who makes investment decisions at the foundation?
Chief Investment Officer Emma Davies is the named lead for the roughly £1 billion endowment. She reports to a board of trustees, with CEO Laurie Lee overseeing the foundation's combined financial, grant-making, and urban health operations. The internal team manages manager selection, direct property development, and co-investment activity.
What is SC1 and how is the foundation involved?
SC1 is the South London health and life sciences innovation district, designed to cluster research institutions, hospitals, and private companies around London Bridge. Guy's & St Thomas' Foundation is a founding partner of SC1 alongside the NHS trust and King's College London. It co-develops key sites within the district, such as Snowsfields Quarter with Oxford Properties.
Does the foundation participate in fund commitments or only direct deals?
It does both. The endowment strategy incorporates institutional fund commitments as well as direct investments and co-investments. The foundation's property operations, led by an internal team, execute direct acquisitions and development partnerships, including joint ventures with Stanhope PLC and Oxford Properties.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: